Baillie Gifford & Co’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $649M | Buy |
18,020,455
+4,618,171
| +34% | +$166M | 0.48% | 39 |
|
|
2025
Q1 | $417M | Sell |
13,402,284
-732,232
| -5% | -$22.8M | 0.36% | 53 |
|
|
2024
Q4 | $361M | Sell |
14,134,516
-1,987,975
| -12% | -$50.7M | 0.28% | 68 |
|
|
2024
Q3 | $456M | Sell |
16,122,491
-230,268
| -1% | -$6.51M | 0.34% | 60 |
|
|
2024
Q2 | $431M | Sell |
16,352,759
-310,033
| -2% | -$8.18M | 0.34% | 60 |
|
|
2024
Q1 | $506M | Sell |
16,662,792
-927,658
| -5% | -$28.2M | 0.39% | 54 |
|
|
2023
Q4 | $494M | Sell |
17,590,450
-650,834
| -4% | -$18.3M | 0.39% | 55 |
|
|
2023
Q3 | $495M | Sell |
18,241,284
-259,304
| -1% | -$7.04M | 0.45% | 52 |
|
|
2023
Q2 | $569M | Sell |
18,500,588
-418,162
| -2% | -$12.9M | 0.48% | 50 |
|
|
2023
Q1 | $682M | Buy |
18,918,750
+1,799,468
| +11% | +$64.8M | 0.62% | 40 |
|
|
2022
Q4 | $677M | Sell |
17,119,282
-748,893
| -4% | -$29.6M | 0.71% | 36 |
|
|
2022
Q3 | $718M | Sell |
17,868,175
-126,743
| -0.7% | -$5.09M | 0.74% | 38 |
|
|
2022
Q2 | $757M | Buy |
17,994,918
+16,867,887
| +1,497% | +$709M | 0.78% | 36 |
|
|
2022
Q1 | $43.9M | Buy |
+1,127,031
| New | +$43.9M | 0.03% | 180 |
|